MiNK Therapeutics
INKT
INKT
18 hedge funds and large institutions have $1.28M invested in MiNK Therapeutics in 2025 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
Holders
18
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$234K | |
| 2 | +$154K | |
| 3 | +$85.9K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$21K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$14.8K |
Top Sellers
| 1 | -$18K | |
| 2 | -$6.27K | |
| 3 | -$3.69K | |
| 4 |
Raymond James Financial
St Petersburg,
Florida
|
-$236 |
| 5 |
BNP Paribas Financial Markets
Paris,
France
|
-$160 |